BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18626283)

  • 41. Mirtazapine for neuroleptic-induced akathisia.
    Poyurovsky M; Weizman A
    Am J Psychiatry; 2001 May; 158(5):819. PubMed ID: 11329417
    [No Abstract]   [Full Text] [Related]  

  • 42. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disability and borderline personality symptoms.
    Sansone RA; Hruschka J; Vasudevan A; Miller SN
    Psychosomatics; 2003; 44(5):442. PubMed ID: 12954928
    [No Abstract]   [Full Text] [Related]  

  • 44. [Mirtazapine--the new standard].
    Fortschr Neurol Psychiatr; 1999 Aug; 67(8 Suppl):1-4. PubMed ID: 10511867
    [No Abstract]   [Full Text] [Related]  

  • 45. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England.
    Biswas PN; Wilton LV; Shakir SA
    J Psychopharmacol; 2003 Mar; 17(1):121-6. PubMed ID: 12680749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mirtazapine and hyperpigmentation.
    Mendhekar D; Inamdar A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
    [No Abstract]   [Full Text] [Related]  

  • 47. Mirtazapine-induced arthralgia.
    Passier A; van Puijenbroek E
    Br J Clin Pharmacol; 2005 Nov; 60(5):570-2. PubMed ID: 16236049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed-onset mirtazapine-related leukopenia and rechallenge.
    Dholakia R; Schleifer SJ; Ahmad YJ; Narang IS
    J Clin Psychopharmacol; 2010 Dec; 30(6):758. PubMed ID: 21057250
    [No Abstract]   [Full Text] [Related]  

  • 49. Mirtazapine as treatment for serotonin syndrome.
    Hoes MJ; Zeijpveld JH
    Pharmacopsychiatry; 1996 Mar; 29(2):81. PubMed ID: 8741027
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of mirtazapine versus fluoxetine on "sleep quality".
    Lawrence RW
    J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
    [No Abstract]   [Full Text] [Related]  

  • 51. Review of the use of mirtazapine in the treatment of depression.
    Benjamin S; Doraiswamy PM
    Expert Opin Pharmacother; 2011 Jul; 12(10):1623-32. PubMed ID: 21644844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mirtazapine-associated hyponatremia presenting as delirium.
    Ghosh A; Hegde A; Grover S
    Indian J Pharmacol; 2014; 46(4):448-9. PubMed ID: 25097290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
    Hundley JL; Yosipovitch G
    J Am Acad Dermatol; 2004 Jun; 50(6):889-91. PubMed ID: 15153889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 58. Serotonin syndrome with mirtazapine-fluoxetine combination.
    Benazzi F
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):495-6. PubMed ID: 9695042
    [No Abstract]   [Full Text] [Related]  

  • 59. No influence of dialysis on mirtazapine - a case report.
    Schlotterbeck PM; Vehren T; Milenovic S; Hiemke C; Kircher T; Leube D
    Pharmacopsychiatry; 2008 Nov; 41(6):259-60. PubMed ID: 19067265
    [No Abstract]   [Full Text] [Related]  

  • 60. New onset multimodal hallucinations associated with mirtazapine: a case report.
    Padala KP; Padala PR; Malloy T; Burke WJ
    Int Psychogeriatr; 2010 Aug; 22(5):837-9. PubMed ID: 20500925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.